http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-20054743-L

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4fda45c540f11df3a7fe71d54a70562a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-429
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-34
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-429
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04
filingDate 2005-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20cc176934a78cca160ca732ffd57dc4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8649c7e388a3bb1883b2041b4322e53d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4974c3cb352a6641082019a06cb478b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_217bdd040531a5bbac8e0b3cdb4c4420
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24e5f92621e1461d12e2b89aeae2dac3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6078e0e8692d0fcbe8432c5676a8fce7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0c1f9bbb088182ae848324af6f8a829
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46f60735883b6c8aa323ec076c02197d
publicationDate 2005-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NO-20054743-L
titleOfInvention Guanidine derivatives and their use as neuropeptide FF receptor antagonists
abstract The invention relates to guanidine derivatives of formula (I) wherein: A = a chain of 3-6 C atoms, one of which may be replaced by -N (R ') - or -O-; and R 1 = H or a substituent; wherein the ring skeleton contains only the two double bonds in the thiazole component; pharmaceutically acceptable acid addition salts of basic compounds of formula (I), pharmaceutically acceptable salts of acid group-containing compounds of formula (I) with bases, pharmaceutically acceptable esters of hydroxy or carboxy group-containing compounds of formula (I) and solvates and hydrates thereof; which are partially known and partially novel and exhibit a neuropeptide FF receptor antagonist effect. The above are suitable for the treatment of pain and hyperalgesia, withdrawal symptoms in the case of alcohol, psychotropic and nicotine dependence, for improving or curing these dependencies, for regulation of insulin secretion, food intake, memory functions, blood pressure, electrolyte - and energy control and for the treatment of urinary incontinence. The above can be prepared using generally used methods and processed into medicaments.
priorityDate 2003-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9256
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974

Total number of triples: 50.